Archive · 10 Jan 2026
TU Study Finds Blood Markers for Early Gallbladder Cancer Detection
Researchers at Tezpur University have found special chemicals in the blood that can help detect gallbladder cancer early.
This type of cancer is very serious and often goes unnoticed until it's too late.
The study looked at blood samples from people with and without gallstones to find these chemicals.
They found different chemicals for each group, which could help doctors create simple blood tests.
This is important because gallbladder cancer is common in Northeast India, and finding it early can save lives.
The researchers worked with doctors and scientists from different places to make this discovery.
They say more studies are needed before these tests can be used in hospitals, but this is a big step forward.
Researchers identified distinct blood-based metabolic signatures for gallbladder cancer with and without gallstones.
The study was published in the 'Journal of Proteome Research' and involved interdisciplinary collaboration.
Gallbladder cancer is prevalent and often undetected in Northeast India, making early diagnosis crucial.
The study analyzed blood samples from three groups: gallbladder cancer without gallstones, gallbladder cancer with gallstones, and gallstones without cancer.
The findings could lead to the development of simple, non-invasive blood tests for early detection of gallbladder cancer.
- Who
- Researchers from Tezpur University, led by Dr Pankaj Barah and Dr Cinmoyee Baruah
- What
- Identified blood-based metabolic signatures for gallbladder cancer detection
- When
- Study published in January 2024
- Where
- Tezpur, Assam, India
- Why
- To aid early diagnosis of gallbladder cancer, which is prevalent and often undetected in Northeast India
- Researchers
- Dr Pankaj Barah, Dr Cinmoyee Baruah
- Institution
- Tezpur University
- Journal
- Journal of Proteome Research
- Metabolites Identified
- 180 (gallstone-free cancer), 225 (gallstone-associated cancer)
- Collaborating Institutions
- Assam Medical College, Dr B Borooah Cancer Institute, Swagat Super-Speciality Hospital, University of Illinois, CSIR–Indian Institute of Toxicology Research
- Region of High Incidence
- Northeast India
- Study Type
- Pilot study